SCHEMBL19034711

SCHEMBL19034711

Oc1ccc(N(c2ccc3c(c2)c2ccccc2n3-c2ccccc2)c2ccc3c(c2)c2ccccc2n3-c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.53
▸ ATM Q13315 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ GAA P10253 1/20 0.45
▸ GFER P55789 1/20 0.45
▸ HPGD P15428 3/20 0.44
▸ HTT P42858 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ KMT2A Q03164 5/20 0.42
▸ MEN1 O00255 4/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19788253 0.96 KDM4E (0.49) KDM4EATML3MBTL1GAAGFER
SCHEMBL13059870 0.94 GAA (0.47) KDM4EATML3MBTL1GAAGFER
SCHEMBL17085498 0.92 KDM4E (0.62) KDM4EATML3MBTL1GAAGFER
SCHEMBL20993670 0.92 KDM4E (0.62) KDM4EATML3MBTL1GAAGFER
SCHEMBL12163943 0.91 KDM4E (0.44) KDM4EATML3MBTL1GAAGFER
SCHEMBL4856298 0.91 GAA (0.43) KDM4EATML3MBTL1GAAGFER
SCHEMBL23352493 0.91 KDM4E (0.60) KDM4EATML3MBTL1GAAGFER
SCHEMBL261695 0.91 KDM4E (0.60) KDM4EATML3MBTL1GAAGFER
SCHEMBL10042885 0.91 KDM4E (0.60) KDM4EATML3MBTL1GAAGFER
SCHEMBL1979204 0.91 KDM4E (0.60) KDM4EATML3MBTL1GAAGFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11563178-B2 Organic electroluminescent element, compound for use in the element, and light emitting device, display device, and illumination device using the element UDC IRELAND LIMITED (IE) 2023-01-24 — — US disclosed
US-20180069179-A1 Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element UDC IRELAND LTD (IE) 2018-03-08 — — US disclosed
US-9691988-B2 Organic electroluminescent element, light-emitting material for organic electroluminescent element, and light-emitting device, display device, and illumination device using said element UDC IRELAND LIMITED (IE) 2017-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180069179-A1 Organic Electroluminescent Element, Compound for Use in the Element, and Light Emitting Device, Display Device, and Illumination Device Using the Element L1CAM, RER1, H1-0 KDM4E 3994/4885ATM 3975/4885L3MBTL1 518/4885
US-11563178-B2 Organic electroluminescent element, compound for use in the element, and light emitting device, display device, and illumination device using the element L1CAM, RER1, H1-0 KDM4E 3994/4885ATM 3975/4885L3MBTL1 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback